A study to assess the effectiveness of chewing gum on reducing oral mucositis and quality of life in patient receiving chemotherapy.
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/05/033616
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
1 Adult patient of age 18yrs or more
2 Patients receiving conventional mucotoxic chemotherapeutic agents(such as Taxane group-Paclitaxel/Docetaxel Antimetabolites-5FU Methotrexate Cytarabine Anthracycline-Doxorubicin Alkylating agents-Cyclophosphamide
3 All new patients going for 1st cycle of conventional mucotoxic chemotherapy
4 Patient with controlled comorbidities
5 Patients with who are able to chew
6 Patients who are able to understand Hindi/English
Exclusion Criteria
1.Baseline NG tube.
2.Evidence of baseline infection.
3.Patients who are unable to chew.
4.Patients who are unable to understand Hindi/English.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method